ADIPOQ and hyperinsulinism: Adipose In addition, etrozole treatment throughout the current study resulted in elevation of abdominal fat, diminished circulating and ovarian adiponectin concentration, insulin resistance, hyperinsulinemia, dyslipidemia, oxidative stress, and hyperandrogenemia, indicating an association with both adiponectin and PCOS metabolic changes.